Verastem, Inc. (LON:0LOV)
10.28
+0.24 (2.44%)
At close: Nov 26, 2025
Verastem Revenue
Verastem had revenue of $11.24M USD in the quarter ending September 30, 2025. In the year 2024, Verastem had annual revenue of $10.00M.
Revenue
$10.00M
Revenue Growth
+33.79%
P/S Ratio
60.29
Revenue / Employee
$128.21K
Employees
78
Market Cap
600.11M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.00M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 2.60M | 543.00K | 26.45% |
| Dec 31, 2021 | 2.05M | -86.46M | -97.68% |
| Dec 31, 2020 | 88.52M | 71.06M | 407.08% |
| Dec 31, 2019 | 17.46M | -9.26M | -34.67% |
| Dec 31, 2018 | 26.72M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Verastem News
- 1 day ago - Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference - Business Wire
- 12 days ago - Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 13 days ago - Verastem Oncology Announces Proposed Public Offering of Common Stock - Business Wire
- 20 days ago - Insider Sell: Dan Paterson Sells Shares of Verastem Inc (VSTM) - GuruFocus
- 21 days ago - Verastem Oncology to Present at Upcoming Investor Conferences - Business Wire
- 22 days ago - Verastem Inc (VSTM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising ... - GuruFocus
- 22 days ago - Q3 2025 Verastem Inc Earnings Call Transcript - GuruFocus
- 22 days ago - Verastem Oncology drops despite Q3 double beat - Seeking Alpha